Researchers at the University of Oklahoma have developed a breakthrough method of adding a single nitrogen atom to molecules, ...

AI drug creation company Absci Corporation (NASDAQ:ABSI) shares are trading higher in premarket on Wednesday after the ...

Chip maker AMD is investing $20 million in AI drug startup Absci, which will use AMD chips and software for drug development.

The deal expands a deal to discover and develop treatments for obesity, type 2 diabetes and cardiovascular disease using ...

IQVIA, Illumina, Mayo Clinic and Arc Institute Harness NVIDIA AI and Accelerated Computing to Transform $10 Trillion ...

The $20 million deal gives the chip supplier a toehold in the life-sciences market, a strategy it plans to replicate in other ...

A new drug to potentially treat depression and neurodegenerative diseases, such as dementia or Parkinson’s, is being ...

Nvidia partners with industry leaders in life sciences to use AI for drug discovery, genomics research, and healthcare innovation. Read more here.

This article provides examples of how AI is helping to shape drug discovery, from drug design through to clinical trials.

With this model, researchers may be able to discover antibody drugs capable of targeting a wide range of infectious diseases.

Absci will use AMD’s $20 million investment to enhance its AI models. In parallel, the companies will collaborate to develop ...

Prostate cancer that has become resistant to hormone therapy could be treated using a new drug that is currently in clinical ...